Mangoceuticals, Inc. MGRX
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 228.70K | 174.60K | 1.49M | 481.30K | 101.00K |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 0.00 | 900.00 | 7.10K | 100.00K | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 17.00K | 37.00K | 54.00K | 16.90K | 16.90K |
| Total Current Assets | 245.70K | 212.50K | 1.55M | 598.20K | 118.00K |
|
|
|||||
| Total Current Assets | 245.70K | 212.50K | 1.55M | 598.20K | 118.00K |
| Net Property, Plant & Equipment | 280.50K | 295.60K | 309.70K | 13.30K | 30.00K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 13.65M | 13.94M | 14.23M | 15.92M | 20.69M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 14.17M | 14.45M | 16.09M | 16.53M | 20.84M |
|
|
|||||
| Total Accounts Payable | 934.70K | 529.80K | 416.70K | 527.00K | 768.00K |
| Total Accrued Expenses | 12.60K | 3.30K | 9.40K | 4.50K | 33.00K |
| Short-term Debt | -- | -- | -- | 100.00K | 600.00K |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 28.30K | 57.10K | 307.80K | 12.20K | 30.10K |
| Total Finance Division Other Current Liabilities | 422.50K | 147.50K | 156.60K | 160.70K | 169.90K |
| Total Other Current Liabilities | 422.50K | 147.50K | 156.60K | 160.70K | 169.90K |
| Total Current Liabilities | 1.40M | 737.60K | 890.60K | 804.30K | 1.60M |
|
|
|||||
| Total Current Liabilities | 1.40M | 737.60K | 890.60K | 804.30K | 1.60M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | 100.00K | 600.00K |
| Capital Leases | 250.90K | 237.00K | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 1.65M | 974.60K | 890.60K | 804.30K | 1.60M |
|
|
|||||
| Common Stock & APIC | 57.57M | 57.21M | 55.53M | 53.28M | 50.80M |
| Retained Earnings | -45.36M | -44.05M | -40.65M | -37.88M | -31.65M |
| Treasury Stock & Other | 319.10K | 321.10K | 321.50K | 322.20K | 97.70K |
| Total Common Equity | 12.53M | 13.48M | 15.20M | 15.73M | 19.24M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 |
|
|
|||||
| Total Common Equity | 12.53M | 13.48M | 15.20M | 15.73M | 19.24M |
| Total Preferred Equity | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 |
| Total Minority Interest | -2.10K | -1.50K | -1.50K | -1.70K | -1.20K |
| Total Equity | 12.52M | 13.47M | 15.20M | 15.73M | 19.24M |
|
|
|||||